|
|
|
Insider
Information: |
Campanelli Paul |
Relationship: |
Chief Executive Office... |
City: |
Woodcliff Lake |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Par Pharmaceutical Companies Inc |
PRX |
Chief Executive Office... |
2012-09-28 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRX |
Par Pharmaceutical Compan... |
Chief Executive Officer |
|
2012-09-28 |
4 |
D |
$50.00 |
$2,300,850 |
D/D |
(46,017) |
0 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Chief Operating Officer |
|
2012-01-11 |
4 |
D |
$35.65 |
$39,286 |
D/D |
(1,102) |
46,106 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Chief Operating Officer |
|
2012-01-06 |
4 |
D |
$34.01 |
$27,412 |
D/D |
(806) |
47,118 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Chief Operating Officer |
|
2012-01-04 |
4 |
D |
$32.17 |
$34,165 |
D/D |
(1,062) |
47,924 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-03-22 |
4 |
D |
$29.00 |
$88,131 |
D/D |
(3,039) |
56,803 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-03-08 |
4 |
S |
$30.57 |
$1,466,397 |
D/D |
(47,720) |
59,842 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-03-08 |
4 |
S |
$30.39 |
$132,738 |
D/D |
(4,350) |
107,562 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-03-07 |
4 |
S |
$30.65 |
$3,249,700 |
D/D |
(105,647) |
122,630 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-03-07 |
4 |
OE |
$10.99 |
$1,688,010 |
D/D |
116,335 |
228,277 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-03-07 |
4 |
S |
$30.95 |
$332,805 |
D/D |
(10,718) |
111,912 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-01-11 |
4 |
D |
$35.98 |
$768,101 |
D/D |
(21,348) |
111,888 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
21,603 |
133,236 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-01-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
8,894 |
111,657 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
8,870 |
111,633 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Par Pharmaceutical |
|
2011-01-04 |
4 |
D |
$37.79 |
$40,133 |
D/D |
(1,062) |
102,763 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Generics |
|
2010-03-22 |
4 |
D |
$25.09 |
$55,198 |
D/D |
(2,200) |
120,340 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP; President - Generics |
|
2010-03-02 |
4 |
OE |
$13.06 |
$324,998 |
D/D |
24,885 |
147,425 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP; President - Generics |
|
2010-03-02 |
4 |
S |
$25.00 |
$623,110 |
D/D |
(24,885) |
122,540 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Generics |
|
2010-01-11 |
4 |
D |
$25.80 |
$65,171 |
D/D |
(2,526) |
122,540 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Generics |
|
2010-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,729 |
125,066 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Generics |
|
2009-12-21 |
4 |
D |
$26.04 |
$47,054 |
D/D |
(1,807) |
113,337 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Generics |
|
2009-03-23 |
4 |
D |
$11.19 |
$24,618 |
D/D |
(2,200) |
146,378 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres-Generics |
|
2009-01-12 |
4 |
D |
$12.59 |
$13,937 |
D/D |
(1,107) |
148,578 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres.-Generics |
|
2009-01-09 |
4 |
D |
$12.83 |
$22,953 |
D/D |
(1,789) |
149,595 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
EVP, Pres.-Generics |
|
2009-01-06 |
4 |
A |
$13.59 |
$14,188 |
D/D |
1,044 |
151,384 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|